More than 80 companies currently claim to offer manufacturing related services.......

Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge.
To order this 300+ page report, which features 140+ figures and 190+ tables, please visit this link
The USD 5.8 billion (by 2030) financial opportunity within the oligonucleotide synthesis, modification and purification services market has been analyzed across the following segments:

• Type of manufacturing

Custom manufacturing
Large-scale manufacturing

• Type of Oligonucleotides manufactured

Antisense Oligonucleotides
miRNAs
shRNAs
siRNAs
Other Oligonucleotides

• Scale of operation

Clinical
Commercial

• Purpose of production

In-house
Outsourced

• Target therapeutic area

Autoimmune Disorders
Cardiovascular Disorders
Genetic Disorders
Infectious Diseases
Metabolic Disorders
Neuromuscular Disorders
Oncological Disorders
Ophthalmic Disorders
Other Therapeutic Areas

• Size of manufacturer

Small
Mid-sized
Large

• Key Geographical Region

North America
Europe
Asia-Pacific and Rest of the World
The Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030 report features the following companies, which we identified to be key players in this domain:

• Agilent Technologies
• Ajinomoto Bio-Pharma Services
• BioSpring
• CordenPharma
• Integrated DNA Technologies
• Kaneka Eurogentec
• LGC Biosearch Technologies
• Microsynth
• Nitto Denko Avecia
• Sigma Aldrich
• Thermo Fisher Scientific
• Trilink Biotechnologies

Table of Contents
1. Preface

2. Executive Summary

3. Introduction


4. Market Landscape: Oligonucleotide Manufacturers (Research and Diagnostic Applications)


5. Market Landscape: Oligonucleotide Manufacturers (Therapeutic Applications)


6. Company Competitiveness Analysis: Oligonucleotide Manufacturers (Research and Diagnostic Applications)


7. Company Competitiveness Analysis: Oligonucleotide Manufacturers (Therapeutic Applications)


8. Company Profiles: Oligonucleotide Manufacturers (Research and Diagnostic Applications)


9. Company Profiles: Oligonucleotide Manufacturers (Therapeutic Applications)


10. Partnerships and Collaborations


11. Recent Expansions


12. Clinical Trial Analysis
 
13. Capacity Analysis
 
14. Demand Analysis


15. Market Sizing and Opportunity Analysis
 
16. Swot Analysis


17. Survey Analysis
 
18. Executive Insights
19. Concluding Remarks
20. Appendix 1: Tabulated Data
21. Appendix 2: List of Companies and Organizations
 
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]